Up First briefing: Trump fights protective order; FDA approves postpartum pill

Prosecutors seek a protective order in Trump’s Jan. 6 legal case, the FDA approves a pill for postpartum depression, and a regional African bloc gives ultimatum to Niger’s coup leaders.

Trump facing legal constraints: The former President’s lawyers have until 5 pm to respond to a request for a protective order in his criminal case related to the Jan. 6 Capitol attack and his attempts to overturn the 2020 election.
* Prosecutor’s request is to limit what Trump and his team can publicly say about the case.
* NRP’s Franco Ordoñez argues that the order aims at preventing potential “chilling effect” Trump’s statements might have on witnesses.
* He expects the effort to delay the case will be a significant issue in the proceedings.

Tensions in Niger: The Economic Community of West African States (ECOWAS) issued an ultimatum to Niger’s coup leaders to restore the ousted President by Sunday or face military intervention.
* Their deadline passed without action, and the military leaders severed diplomatic ties with the U.S., Nigeria and France in preparation for self-defense.
* NPR’s Emmanuel Akinwotu anticipates that a military intervention appears increasingly unlikely, but warns of escalating regional conflict.

FDA Approves Postpartum Treatment: The FDA has given its approval to the first pill targeted at postpartum depression.
* The pill, developed by Sage Therapeutics, is taken daily for 14 days, with results visible as early as the third day in many patients.
* While Rutgers University’s Assistant Professor of Nursing Jamille Nagtalon-Ramos recognizes the potential benefits, concerns remain about the long-term effects and possible pricing barriers.

View original article on NPR

This summary was created by an AI system. The use of this summary is subject to our Terms of Service.

Contact us about this post






Leave a Reply

Your email address will not be published. Required fields are marked *